Rothenberger, Sylvia http://orcid.org/0000-0001-8633-2994
Hurdiss, Daniel L.
Walser, Marcel
Malvezzi, Francesca
Mayor, Jennifer
Ryter, Sarah
Moreno, Hector
Liechti, Nicole http://orcid.org/0000-0003-4354-2419
Bosshart, Andreas
Iss, Chloé
Calabro, Valérie
Cornelius, Andreas
Hospodarsch, Tanja
Neculcea, Alexandra
Looser, Thamar
Schlegel, Anja
Fontaine, Simon
Villemagne, Denis http://orcid.org/0000-0002-4465-364X
Paladino, Maria
Schiegg, Dieter
Mangold, Susanne
Reichen, Christian
Radom, Filip
Kaufmann, Yvonne
Schaible, Doris
Schlegel, Iris
Zitt, Christof
Sigrist, Gabriel
Straumann, Marcel
Wolter, Julia
Comby, Marco
Sacarcelik, Feyza
Drulyte, Ieva
Lyoo, Heyrhyoung http://orcid.org/0000-0001-5806-9463
Wang, Chunyan
Li, Wentao
Du, Wenjuan
Binz, H. Kaspar http://orcid.org/0000-0003-0702-2280
Herrup, Rachel
Lusvarghi, Sabrina http://orcid.org/0000-0003-1793-0450
Neerukonda, Sabari Nath
Vassell, Russell
Wang, Wei
Adler, Julia M. http://orcid.org/0000-0001-8147-0351
Eschke, Kathrin
Nascimento, Mariana
Abdelgawad, Azza
Gruber, Achim D.
Bushe, Judith http://orcid.org/0000-0001-6103-3277
Kershaw, Olivia
Knutson, Charles G.
Balavenkatraman, Kamal K.
Ramanathan, Krishnan
Wyler, Emanuel http://orcid.org/0000-0002-9884-1806
Teixeira Alves, Luiz Gustavo
Lewis, Seth
Watson, Randall
Haeuptle, Micha A.
Zürcher, Alexander
Dawson, Keith M. http://orcid.org/0000-0002-1770-291X
Steiner, Daniel
Weiss, Carol D. http://orcid.org/0000-0002-9965-1289
Amstutz, Patrick
van Kuppeveld, Frank J. M.
Stumpp, Michael T. http://orcid.org/0000-0001-7356-2061
Bosch, Berend-Jan http://orcid.org/0000-0002-3864-232X
Engler, Olivier http://orcid.org/0000-0002-8404-1496
Trimpert, Jakob http://orcid.org/0000-0003-1616-0810
Article History
Received: 14 December 2021
Accepted: 2 June 2022
First Online: 21 July 2022
Competing interests
: Authors employed by Molecular Partners own performance share units and/or stock of the company. H.K.B. owns stock of the company. I.D. is an employee of Thermo Fisher Scientific. C.K., K.B. and K.R. are employees of Novartis. Ensovibep is patent protected by Molecular Partners (with Novartis owning the global rights); names of inventors: Patrick Amstutz, Valérie Perrine Calabro and Marcel Walser; patent number: WO 2021/224686 A1; published on 11 November 2021. Funding sources are provided in the Acknowledgements. The other authors declare no competing interests.